Latest filing published 13 Dec 2011 for ADOLOR CORP, €5.5M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Cubist Pharmaceuticals Inc: trading record in brief
This profile gathers the share dealings of Cubist Pharmaceuticals Inc in Adolor Corp. In total, 5 filings cover trades dated from 7 December 2011 to 12 December 2011.
No open-market sale appears; the market trades are 5 purchases worth €208.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
A typical purchase (the median) is worth €13.6M.
The record was last updated on 13 December 2011 with an open-market purchase (€5.5M) in Adolor Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Cubist Pharmaceuticals Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,729,130 shares@ US$4.25Common Stock, $0.0001 par valueSEC:0001104659-11-069251:0Canonical exit: 8 Mar 2012 (T+90)
- 45,070,030 shares@ US$4.76Common Stock, $0.0001 par valueSEC:0001104659-11-069251:1Canonical exit: 8 Mar 2012 (T+90)
- 7,908,727 shares@ US$4.25Common Stock, $0.0001 par valueSEC:0001104659-11-069251:2Canonical exit: 11 Mar 2012 (T+90)
- 4,306,129 shares@ US$4.25Common Stock, $0.0001 par valueSEC:0001104659-11-068718:0Canonical exit: 6 Mar 2012 (T+90)
- 1,180,983 shares@ US$4.25Common Stock, $0.0001 par valueSEC:0001104659-11-068718:1Canonical exit: 7 Mar 2012 (T+90)
5 of 5 declarations
